omeprazole has been researched along with Erosive Duodenitis in 24 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open clinical trial, 16 hospital outpatients with endoscopically proven duodenal ulcer were given 30 mg omeprazole once daily for four weeks." | 9.06 | Effect and tolerability of omeprazole in the treatment of duodenal ulcer disease. ( Jonsson, E; Labó, G; Rinetti, M; Tomassetti, P; Vezzadini, P, 1986) |
| "To study the prevalence of Helicobacter pylori infection in patients with erosive duodenitis (ED), the associated gastric histological lesions and their response to eradication therapy with omeprazole plus two antibiotics." | 7.69 | Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics. ( Bermejo, F; Boixeda, D; de Argila, CM; de Rafael, L; Gisbert, JP; Redondo, C, 1997) |
| "Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss." | 5.29 | Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996) |
| "To compare the efficacy of either omeprazole or ranitidine in a second-line quadruple regimen in patients with duodenal ulcer or erosive duodenitis." | 5.09 | Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens. ( Balta, A; Bouzakis, H; Broutet, N; Kralios, N; Michopoulos, S; Tsibouris, P; Vougadiotis, J, 2000) |
| "In an open clinical trial, 16 hospital outpatients with endoscopically proven duodenal ulcer were given 30 mg omeprazole once daily for four weeks." | 5.06 | Effect and tolerability of omeprazole in the treatment of duodenal ulcer disease. ( Jonsson, E; Labó, G; Rinetti, M; Tomassetti, P; Vezzadini, P, 1986) |
| "To study the prevalence of Helicobacter pylori infection in patients with erosive duodenitis (ED), the associated gastric histological lesions and their response to eradication therapy with omeprazole plus two antibiotics." | 3.69 | Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics. ( Bermejo, F; Boixeda, D; de Argila, CM; de Rafael, L; Gisbert, JP; Redondo, C, 1997) |
| "Posttreatment clarithromycin resistance is common in patients who do not experience success with therapy." | 2.68 | Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. ( Axon, AT; Chalmers, DM; Dixon, MF; Langworthy, H; Moayyedi, P; Shanahan, K; Tompkins, DS, 1996) |
| "Omeprazole was found to induce a significant reduction (p less than 0." | 2.67 | Omeprazole-induced changes in gastric mucus secretion. ( Fanti, L; Franceschi, M; Guslandi, M; Pellegrini, A; Tittobello, A, 1992) |
| " In a group of 34 patients studied prospectively, high dosage (300 mg orally bid) therapy with the H2-antagonist ranitidine for 8 wk significantly improved symptoms and endoscopic appearance (p < 0." | 1.29 | Clinical and pathologic features of the nodular duodenum. ( Triadafilopoulos, G, 1993) |
| "Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss." | 1.29 | Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunicki, PK | 1 |
| Sobieszczańska-Małek, M | 1 |
| Sakaki, N | 1 |
| Czerwionka-Szaflarska, M | 1 |
| Brazowski, J | 1 |
| Li, XB | 1 |
| Ge, ZZ | 1 |
| Chen, XY | 1 |
| Liu, WZ | 1 |
| Kori, M | 1 |
| Cohen, S | 1 |
| Levine, A | 1 |
| Givony, S | 1 |
| Sokolovskaia-Ziv, N | 1 |
| Melzer, E | 1 |
| Granot, E | 1 |
| Kadayifçi, A | 1 |
| Simsek, H | 1 |
| Arslan, M | 1 |
| Tatar, G | 1 |
| Adamek, RJ | 2 |
| Szymanski, C | 1 |
| Pfaffenbach, B | 1 |
| Opferkuch, W | 2 |
| Ricken, D | 1 |
| Wegener, M | 2 |
| Logan, RP | 1 |
| Gummett, PA | 1 |
| Schaufelberger, HD | 1 |
| Greaves, RR | 1 |
| Mendelson, GM | 1 |
| Walker, MM | 1 |
| Thomas, PH | 1 |
| Baron, JH | 1 |
| Misiewicz, JJ | 1 |
| Triadafilopoulos, G | 1 |
| Khulusi, S | 1 |
| Badve, S | 1 |
| Patel, P | 1 |
| Lloyd, R | 1 |
| Marrero, JM | 1 |
| Finlayson, C | 1 |
| Mendall, MA | 1 |
| Northfield, TC | 1 |
| Murata, I | 1 |
| Yoshikawa, I | 1 |
| Kuroda, T | 1 |
| Tabaru, A | 1 |
| Miura, T | 1 |
| Otsuki, M | 1 |
| Tan, WC | 1 |
| Hogan, J | 1 |
| Purkayastha, SK | 1 |
| Lombard, M | 1 |
| Krasner, N | 1 |
| Gisbert, JP | 1 |
| Boixeda, D | 1 |
| de Argila, CM | 1 |
| Bermejo, F | 1 |
| Redondo, C | 1 |
| de Rafael, L | 1 |
| Moayyedi, P | 1 |
| Langworthy, H | 1 |
| Shanahan, K | 1 |
| Tompkins, DS | 1 |
| Dixon, MF | 1 |
| Chalmers, DM | 1 |
| Axon, AT | 1 |
| Brieva, L | 1 |
| Ara, JR | 1 |
| Bertol, V | 1 |
| Canellas, A | 1 |
| del Agua, C | 1 |
| Michopoulos, S | 1 |
| Tsibouris, P | 1 |
| Bouzakis, H | 1 |
| Balta, A | 1 |
| Vougadiotis, J | 1 |
| Broutet, N | 1 |
| Kralios, N | 1 |
| Plein, K | 1 |
| Madisch, A | 1 |
| Stolte, M | 1 |
| Hotz, J | 1 |
| Vichev, E | 1 |
| Krŭstev, N | 1 |
| Krŭstev, D | 1 |
| Baeva, N | 1 |
| Kiselova, A | 1 |
| Ianev, N | 1 |
| Mai, AL | 1 |
| Mai, KT | 1 |
| Guslandi, M | 1 |
| Franceschi, M | 1 |
| Fanti, L | 1 |
| Pellegrini, A | 1 |
| Tittobello, A | 1 |
| Marks, DR | 1 |
| Joy, JV | 1 |
| Bonheim, NA | 1 |
| Haga, K | 1 |
| Asano, K | 1 |
| Osuga, K | 1 |
| Maruyama, Y | 1 |
| Rinetti, M | 1 |
| Vezzadini, P | 1 |
| Jonsson, E | 1 |
| Tomassetti, P | 1 |
| Labó, G | 1 |
2 reviews available for omeprazole and Erosive Duodenitis
| Article | Year |
|---|---|
[Gastroduodenal erosions observed after Helicobacter pylori eradication].
Topics: Adult; Amoxicillin; Clarithromycin; Duodenitis; Helicobacter Infections; Helicobacter pylori; Histam | 2005 |
[Proton pump inhibitors in developmental period medicine].
Topics: Adult; Age Factors; Anti-Ulcer Agents; Child; Drug Interactions; Duodenitis; Enzyme Inhibitors; Esom | 2007 |
8 trials available for omeprazole and Erosive Duodenitis
| Article | Year |
|---|---|
Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease.
Topics: Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Helicobacter Infections; Heli | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom | 1995 |
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Du | 1996 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; | 1997 |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Clarithromycin; Drug Therapy | 1996 |
Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; | 2000 |
Omeprazole-induced changes in gastric mucus secretion.
Topics: Adult; Double-Blind Method; Duodenitis; Female; Follow-Up Studies; Gastric Mucosa; Humans; Male; Mid | 1992 |
Effect and tolerability of omeprazole in the treatment of duodenal ulcer disease.
Topics: Adult; Aged; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer; Duodenitis; Female; Humans | 1986 |
14 other studies available for omeprazole and Erosive Duodenitis
| Article | Year |
|---|---|
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.
Topics: Area Under Curve; Azathioprine; Clarithromycin; Drug Administration Schedule; Drug Interactions; Duo | 2005 |
Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duode | 2007 |
Collagenous gastritis: a rare cause of abdominal pain and iron-deficiency anemia.
Topics: Abdominal Pain; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Biopsy; Child; Collagen; Collagen Diseas | 2007 |
Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination | 1994 |
Eradication of Helicobacter pylori with clarithromycin and omeprazole.
Topics: Adult; Aged; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; | 1994 |
Clinical and pathologic features of the nodular duodenum.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Duodenal Diseases; Duodenitis; Duodenoscopy; Duodenum; Human | 1993 |
Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole.
Topics: Adult; Duodenitis; Enzyme Inhibitors; Female; Gastric Mucosa; Gastritis; Gastroscopy; Humans; Intest | 1996 |
Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenitis; Female | 1997 |
[Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis].
Topics: Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Antiprotozoal Agents; Bismuth; Duodenitis; E | 1998 |
Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy, | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther | 2000 |
Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Diagnosis, Dif | 2001 |
Hemolytic anemia associated with the use of omeprazole.
Topics: Anemia, Hemolytic; Duodenitis; Esophagitis, Peptic; Female; Humans; Middle Aged; Omeprazole; Peptic | 1991 |
[Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
Topics: Animals; Dogs; Duodenitis; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Male; Omepraz | 1988 |